Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Operating cash flow minus capital expenditures
3Y CAGR
+188.1%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
23.9x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $136.42M | +436.8% |
| 2024 | $25.41M | +92.9% |
| 2023 | $13.17M | +131.0% |
| 2022 | $5.70M | +103.9% |
| 2021 | $-146.71M | -7.2% |
| 2020 | $-136.81M | +15.3% |
| 2019 | $-161.57M | -87.2% |
| 2018 | $-86.30M | -71.6% |
| 2017 | $-50.29M | -129.9% |
| 2016 | $-21.87M | - |